Jeff Andrews, MD, FRCSC, Vice President of Medical Affairs for Integrated Diagnostic Solutions at BD, discusses the link between human papillomavirus (HPV) and cervical cancer, and how HPV self-sampling kits may increase rates of cervical cancer screening.
Anne Banfield, MD, discusses the highlights from her presentation on primary HPV screening at the 2023 ACOG Annual Clinical and Scientific Meeting in Baltimore, Maryland.
In a recent study, under-screened patients were more likely to receive cervical cancer screening after receiving at-home high-risk human papillomavirus sampling kits.
When examining studies on cervical cerclage placement and complications, reviewers found complications were most common in physical examination-indicated cerclage and least common in history-indicated cerclage.
In a recent study, patients receiving interventions designed to increase adherence to screenings for breast, cervical, or colorectal cancers were more likely to be up to date on any or all screenings.
January is Cervical Cancer Awareness Month. Check out the most up-to-date statistics on HPV and cervical cancer.
This month is a perfect opportunity for ob-gyns and other women’s health care providers to raise awareness about cervical cancer and HPV vaccination.
Although human papillomavirus testing with urine is slightly less sensitive than using cervical samples, it may be easier for women than going to a doctor’s office for a Pap smear.
